CA2331333A1 - Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues - Google Patents

Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues Download PDF

Info

Publication number
CA2331333A1
CA2331333A1 CA002331333A CA2331333A CA2331333A1 CA 2331333 A1 CA2331333 A1 CA 2331333A1 CA 002331333 A CA002331333 A CA 002331333A CA 2331333 A CA2331333 A CA 2331333A CA 2331333 A1 CA2331333 A1 CA 2331333A1
Authority
CA
Canada
Prior art keywords
relates
arabinofuranose
analogues
beta
antisense oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002331333A
Other languages
English (en)
Other versions
CA2331333C (fr
Inventor
Massad Jose Damha
Michael A. Parniak
Anne M. Noronha
Christopher Wilds
Gadip Borkow
Dominique Arion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
Mcgill University
Massad Jose Damha
Michael A. Parniak
Anne M. Noronha
Christopher Wilds
Gadip Borkow
Dominique Arion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcgill University, Massad Jose Damha, Michael A. Parniak, Anne M. Noronha, Christopher Wilds, Gadip Borkow, Dominique Arion filed Critical Mcgill University
Priority to CA002331333A priority Critical patent/CA2331333C/fr
Priority to CA002618288A priority patent/CA2618288A1/fr
Priority claimed from PCT/CA1999/000571 external-priority patent/WO1999067378A1/fr
Publication of CA2331333A1 publication Critical patent/CA2331333A1/fr
Application granted granted Critical
Publication of CA2331333C publication Critical patent/CA2331333C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/334—Modified C
    • C12N2310/3341—5-Methylcytosine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002331333A 1998-06-19 1999-06-17 Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues Expired - Fee Related CA2331333C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002331333A CA2331333C (fr) 1998-06-19 1999-06-17 Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues
CA002618288A CA2618288A1 (fr) 1998-06-19 1999-06-17 Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA2,241,361 1998-06-19
CA2241361 1998-06-19
CA002331333A CA2331333C (fr) 1998-06-19 1999-06-17 Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues
PCT/CA1999/000571 WO1999067378A1 (fr) 1998-06-19 1999-06-17 CONSTRUCTIONS OLIGONUCLEOTIDES ANTISENSE A BASE DE β-ARABINOFURANOSE ET DE SES ANALOGUES

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002618288A Division CA2618288A1 (fr) 1998-06-19 1999-06-17 Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues

Publications (2)

Publication Number Publication Date
CA2331333A1 true CA2331333A1 (fr) 1999-12-29
CA2331333C CA2331333C (fr) 2008-05-20

Family

ID=25680318

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002331333A Expired - Fee Related CA2331333C (fr) 1998-06-19 1999-06-17 Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues
CA002618288A Abandoned CA2618288A1 (fr) 1998-06-19 1999-06-17 Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002618288A Abandoned CA2618288A1 (fr) 1998-06-19 1999-06-17 Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues

Country Status (1)

Country Link
CA (2) CA2331333C (fr)

Also Published As

Publication number Publication date
CA2618288A1 (fr) 1999-12-29
CA2331333C (fr) 2008-05-20

Similar Documents

Publication Publication Date Title
AU4595399A (en) Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues
WO2003100017A3 (fr) Oligonucleotides a unites nucleosides modifiees
CA2177732A1 (fr) Oligonucleotides antisens inhibant l'oncogenicite
WO2002026967A3 (fr) Correction de gene cible au moyen d'oligodesoxynucleotides monocatenaires
EP2752488A3 (fr) Conception antisens
AU5121399A (en) Rna targeted 2'-modified oligonucleotides that are conformationally preorganized
WO2001092512A3 (fr) Modifications genomiques chromosomiques ciblees dans des plantes mettant en application des oligonucleotides monocatenaires modifies
ZA200304500B (en) Method for inhibiting the expression of a target gene and medicament for treating a tumor disease.
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
EP1160318A3 (fr) Médicament pour le traitement de la dystrophie musculaire de Duchenne
EP0961837A4 (fr) Oligonucleotides antisens chimeres a trois composants
AU3617597A (en) Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
AU6589094A (en) 7-deazapurine modified oligonucleotides
EP1485401A4 (fr) Therapie par antisens trpm-2 utilisant un oligonucleotide presentant des modification de 2'-o-(2-methoxyl)ethyle
EP3040423A3 (fr) Micro-arn et ses utilisations
WO2001032832A3 (fr) Modulation antisens de l'expression de la nucleoline
WO2006102970A3 (fr) Petit arn interferant modifie
WO2002020773A3 (fr) Antisens chimerique d'analogues de l'arabinofuranose analogue et nucleotides de desoxyribose
WO2000029623A3 (fr) Acides nucleiques contenant des polymorphismes d'un seul nucleotide et utilisations de ces acides nucleiques
AU3295700A (en) Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
CA2495298A1 (fr) Utilisation d'oligonucleotides antisens pour inhiber l'expression de akt-1
WO2000008140A3 (fr) Oligonucleotides antisens destines a inhiber l'expression de vegf
CA2331333A1 (fr) Constructions oligonucleotides antisense a base de .beta.-arabinofuranose et de ses analogues
WO2001048245A3 (fr) Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d'utilisation correspondants
WO2001040521A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed